BioNexus Gene Lab
BGLC
BGLC
5 hedge funds and large institutions have $171K invested in BioNexus Gene Lab in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$50K | |
| 2 | +$43.5K | |
| 3 | +$38K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$20K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.9K |
Top Sellers
No sellers this quarter